dna amplification efficiencies (Thermo Fisher)
Structured Review
Dna Amplification Efficiencies, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+amplification+efficiencies/DNA/pm38176658-97-15-21
Average 99 stars, based on 1 article reviews
Images
Related Articles
DNA Amplification:Article Title: Integrating rapid pathogen identification and antimicrobial susceptibility testing through multiplex TaqMan qPCR assay. Article Snippet: Timely bacterial identification (ID) and antimicrobial susceptibility testing (AST) are of significance for therapy of bacteria-infected patients.. In the present study, we developed a multiplex TaqMan qPCR assay for rapid and accurate ID and AST of three common hospital acquired pneumonia species, namely Acinetobacter baumannii, Klebsiella pneumoniae and Staphylococcus aureus.. In this assay, DNA extraction and bacterial co-incubation with antibiotics are accomplished based on a common PCR instrument. Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and Lysis:Article Title: Integrating rapid pathogen identification and antimicrobial susceptibility testing through multiplex TaqMan qPCR assay. Article Snippet: Timely bacterial identification (ID) and antimicrobial susceptibility testing (AST) are of significance for therapy of bacteria-infected patients.. In the present study, we developed a multiplex TaqMan qPCR assay for rapid and accurate ID and AST of three common hospital acquired pneumonia species, namely Acinetobacter baumannii, Klebsiella pneumoniae and Staphylococcus aureus.. In this assay, DNA extraction and bacterial co-incubation with antibiotics are accomplished based on a common PCR instrument. DNA Extraction:Article Title: Integrating rapid pathogen identification and antimicrobial susceptibility testing through multiplex TaqMan qPCR assay. Article Snippet: Timely bacterial identification (ID) and antimicrobial susceptibility testing (AST) are of significance for therapy of bacteria-infected patients.. In the present study, we developed a multiplex TaqMan qPCR assay for rapid and accurate ID and AST of three common hospital acquired pneumonia species, namely Acinetobacter baumannii, Klebsiella pneumoniae and Staphylococcus aureus.. In this assay, DNA extraction and bacterial co-incubation with antibiotics are accomplished based on a common PCR instrument. AST Assay:Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and Control:Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and Real-time Polymerase Chain Reaction:Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and Sample Prep:Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and Reverse Transcription:Article Title: Testing device, microfluidic chip and nucleic acid testing method Article Snippet: .. No. mRNA Target CFX96 Touch TM Microfluidic Chip 1 AST - Control 20.07 ± 0.02 20.5 ± 0.2 2 AST - 3x Dosage 19.34 ± 0.05 19.9 ± 0.2 3 ALT - Control 27.28 ± 0.10 28.8 ± 0.2 4 ALT - 3x Dosage 26.75 ± 0.07 28.5 ± 0.3 5 β-Actin - Control 22.93 ± 0.11 23.0 ± 0.2 6 β-Actin - 3x Dosage 23.02 ± 0.08 23.1 ± 0.2 The presence of the housekeeping gene, β-actin, allowed the inventors to normalize the qPCR experimental data, to minimize possible variations from the experimental setup such as sample preparation and handling, reverse transcription efficiency between sample-sample/run-run repetitions, and |
